Takeda
@TakedaPharma
Some post-transplant patients with cytomegalovirus (#CMV) face the challenge of safely swallowing solid tablets. The FDA has expanded the administration of our oral medication to include nasogastric/orogastric tubes. Learn more about transplants: bit.ly/3UGDVa5 #USOnly
5 5